ResearcherNational Cancer Institute (NCI)Active in the last 2 years

M.D. Nicholas D Klemen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2025: 1 trial

Trials 1

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies Principal investigator NCT06690281 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.